Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 270 entries
View as:

A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00640016 Org: User:
Start: 01/31/08 End: 07/31/08 Due: 07/31/09

Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT00192491 Org: User:
Start: 12/31/00 End: 12/31/03 Due: 12/31/04

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02200770 Org: User:
Start: 04/01/15 End: 11/06/20 Due: 11/06/21

Long-Term Follow-Up Study of Psoriasis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00131066 Org: User:
Start: 08/31/02 End: 12/31/07 Due: 12/31/08

BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00126646 Org: User:
Start: 06/30/05 End: 06/30/09 Due: 06/30/10

Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00125944 Org: User:
Start: 07/31/05 End: 01/31/06 Due: 01/31/07

Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT03143101 Org: User:
Start: 05/08/17 End: 09/29/17 Due: 09/29/18

MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)

Phase: N/A Priority: Normal
NCT ID: NCT02549651 Org: User:
Start: 07/13/16 End: 02/04/19 Due: 02/04/20

Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03654313 Org: User:
Start: 09/28/18 End: 07/21/20 Due: 07/21/21

A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00587457 Org: User:
Start: 03/07/07 End: 04/07/08 Due: 04/07/09

To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT02601560 Org: User:
Start: 12/03/15 End: 11/03/16 Due: 11/03/17

A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL

Phase: N/A Priority: Normal
NCT ID: NCT01544348 Org: User:
Start: 01/31/12 End: 06/30/13 Due: 06/30/14

Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)

Phase: N/A Priority: Normal
NCT ID: NCT00192387 Org: User:
Start: 09/30/01 End: 12/31/01 Due: 12/31/02

A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00628303 Org: User:
Start: 10/31/10 End: 12/31/11 Due: 12/31/12

A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01715896 Org: User:
Start: 03/31/13 End: 02/28/15 Due: 02/28/16

A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT03555994 Org: User:
Start: 05/31/18 End: 04/14/21 Due: 04/14/22

Study To Evaluate the Safety of Bivalent Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00325481 Org: User:
Start: 06/30/06 End: 12/31/06 Due: 12/31/07

A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft Rejection

Phase: N/A Priority: Normal
NCT ID: NCT00807794 Org: User:
Start: 02/28/97 End: 01/31/98 Due: 01/31/99

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00128167 Org: User:
Start: 10/31/04 End: 12/31/05 Due: 12/31/06

An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants

Phase: N/A Priority: Normal
NCT ID: NCT00369759 Org: User:
Start: 09/30/06 End: 09/30/08 Due: 09/30/09

A Phase 1/2 Study of MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT02576548 Org: User:
Start: 09/23/15 End: 05/23/18 Due: 05/23/19

A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02705482 Org: User:
Start: 03/30/16 End: 08/07/19 Due: 08/07/20

An Observational Study to Assess RSV-associated Illness in Adults With COPD and/or CHF

Phase: N/A Priority: Normal
NCT ID: NCT01455402 Org: User:
Start: 07/31/10 End: 05/31/14 Due: 05/31/15

A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis

Phase: N/A Priority: Normal
NCT ID: NCT00533091 Org: User:
Start: 04/30/08 End: 10/31/10 Due: 10/31/11

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00540618 Org: User:
Start: 09/30/01 End: 07/31/03 Due: 07/31/04